drugset / Trial / NCT02378129

Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

NCT02378129 ↗

Phase 2/3 Completed 20 enrolled Federal University of Pelotas
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Timeline

Start
2014-04-02
Primary completion
2015-04-01
Completion
2015-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clinpro XT Other / unclassified — —
Comparator Vidrion R Other / unclassified — —

Indications